NOVOSEVEN 5 mg (250 KUI), powder and solvent for solution for injection bottle
Active ingredients: EPTACOG ALFA (ACTIVÉ)
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NOVOSEVEN 5 mg (250 KUI), poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre avec adaptateur(s) pour flacon
- Marketing authorisation holder
- NOVO NORDISK (DANEMARK)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 Aug 2015
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66390405CIP75838446CIP133400958384462Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| EPTACOG ALFA (ACTIVÉ)poudre | 5 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.